BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19565553)

  • 1. Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis.
    Fertig N; Domsic RT; Rodriguez-Reyna T; Kuwana M; Lucas M; Medsger TA; Feghali-Bostwick CA
    Arthritis Rheum; 2009 Jul; 61(7):958-65. PubMed ID: 19565553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative Review.
    Fritzler MJ; Bentow C; Beretta L; Palterer B; Perurena-Prieto J; Sanz-Martínez MT; Guillen-Del-Castillo A; Marín A; Fonollosa-Pla V; Callejas-Moraga E; Simeón-Aznar CP; Mahler M
    Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare scleroderma autoantibodies to the U11 small nuclear ribonucleoprotein and to the trimethylguanosine cap of U small nuclear RNAs.
    Gilliam AC; Steitz JA
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6781-5. PubMed ID: 8341699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-U3 RNP autoantibodies in systemic sclerosis.
    Aggarwal R; Lucas M; Fertig N; Oddis CV; Medsger TA
    Arthritis Rheum; 2009 Apr; 60(4):1112-8. PubMed ID: 19333934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.
    Steen V; Domsic RT; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2012 Sep; 64(9):2986-94. PubMed ID: 22576620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.
    Rodriguez-Reyna TS; Hinojosa-Azaola A; Martinez-Reyes C; Nuñez-Alvarez CA; Torrico-Lavayen R; García-Hernández JL; Cabiedes-Contreras J
    Autoimmunity; 2011 Nov; 44(7):576-84. PubMed ID: 21875377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-RNPC-3 antibody predicts poor prognosis in patients with interstitial lung disease associated to systemic sclerosis.
    Callejas-Moraga EL; Guillén-Del-Castillo A; Perurena-Prieto J; Sanz-Martínez MT; Fonollosa-Pla V; Lorite-Gomez K; Severino A; Bellocchi C; Beretta L; Mahler M; Simeón-Aznar CP
    Rheumatology (Oxford); 2021 Dec; 61(1):154-162. PubMed ID: 33742673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-RNPC-3 (U11/U12) Antibodies in Systemic Sclerosis in Patients With Moderate-to-Severe Gastrointestinal Dysmotility.
    McMahan ZH; Domsic RT; Zhu L; Medsger TA; Casciola-Rosen L; Shah AA
    Arthritis Care Res (Hoboken); 2019 Sep; 71(9):1164-1170. PubMed ID: 30242973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.
    Cavazzana I; Vojinovic T; Airo' P; Fredi M; Ceribelli A; Pedretti E; Lazzaroni MG; Garrafa E; Franceschini F
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):412-430. PubMed ID: 35716254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
    Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
    Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-C1q autoantibodies are frequently detected in patients with systemic sclerosis associated with pulmonary fibrosis.
    Liaskos C; Rentouli S; Simopoulou T; Gkoutzourelas A; Norman GL; Brotis A; Alexiou I; Katsiari C; Bogdanos DP; Sakkas LI
    Br J Dermatol; 2019 Jul; 181(1):138-146. PubMed ID: 30875084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody profile in a cohort of Algerian patients with systemic sclerosis.
    Tahiat A; Allam I; Abdessemed A; Mellal Y; Nebbab R; Ladjouze-Rezig A; Djidjik R
    Ann Biol Clin (Paris); 2020 Apr; 78(2):126-133. PubMed ID: 32175889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis.
    Okano Y; Medsger TA
    Arthritis Rheum; 1990 Dec; 33(12):1822-8. PubMed ID: 1701994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    Sobanski V; Giovannelli J; Lynch BM; Schreiber BE; Nihtyanova SI; Harvey J; Handler CE; Denton CP; Coghlan JG
    Arthritis Rheumatol; 2016 Feb; 68(2):484-93. PubMed ID: 26415038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.
    Mierau R; Moinzadeh P; Riemekasten G; Melchers I; Meurer M; Reichenberger F; Buslau M; Worm M; Blank N; Hein R; Müller-Ladner U; Kuhn A; Sunderkötter C; Juche A; Pfeiffer C; Fiehn C; Sticherling M; Lehmann P; Stadler R; Schulze-Lohoff E; Seitz C; Foeldvari I; Krieg T; Genth E; Hunzelmann N
    Arthritis Res Ther; 2011; 13(5):R172. PubMed ID: 22018289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Frequency of Activated Switched Memory B Cells and Its Association With the Presence of Pulmonary Fibrosis in Diffuse Cutaneous Systemic Sclerosis Patients.
    Simon D; Balogh P; Erdő-Bonyár S; Böröcz K; Minier T; Czirják L; Berki T
    Front Immunol; 2021; 12():686483. PubMed ID: 34276673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
    Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA
    J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.